Townsend Richard Nolan's Form 4 filing
Lexeo Therapeutics, Inc. (LXEO) · filed Oct 17, 2025
- Accession no.
- 0001995218-25-000005
- Filed
- Oct 17, 2025
- Trade date
- Oct 15-17, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $117.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Townsend Richard NolanCIK 0001995218 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 15, 2025 | Common Stock | AGrant or awardAcquired | +33,000 | $0.00 | $0 | 255,251 | Direct | |
| Oct 17, 2025 | Common Stock | SSaleDisposed | −12,985 | $8.94 | −$116,085.9 | 242,266 | Direct | |
| Oct 17, 2025 | Common Stock | SSaleDisposed | −148 | $9.56 | −$1,414.88 | 242,118 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.